Company profile for PEDIATRIC PHARMACEUTICALS INC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pediatric Pharmaceuticals, Inc. (PPI) was formed to develop and market unique pharmaceutical products designed to fulfill the needs of the medical community. Its first product CAFCIT, caffeine citrate for apnea of prematurity, received FDA approval in September 1999 and is now on the market throughout the U.S. PPI plans to target the development of pharmaceuticals, many of which will qualify as orphan drugs capa...
Pediatric Pharmaceuticals, Inc. (PPI) was formed to develop and market unique pharmaceutical products designed to fulfill the needs of the medical community. Its first product CAFCIT, caffeine citrate for apnea of prematurity, received FDA approval in September 1999 and is now on the market throughout the U.S. PPI plans to target the development of pharmaceuticals, many of which will qualify as orphan drugs capable of obtaining the financial/patent benefits of the Orphan Drug Act. Major drug companies are usually not interested in these products because of their relatively small sales potential. The Company also feels that once certain specialty products are approved, they may find a larger audience through use in other indications. As long term strategy, PPI plans to identify and financially support selected university and hospital research projects that offer strong potential as major pediatric and adult products. This investment program should provide the Company with a stream of new and innovative products as well as foster formal relationships with leading medical research centers. PPI first became interested in thalidomide after supplying the product for children and adults afflicted with leprosy at the Hansen's Disease Center in Carville, LA. An analysis of existing literature indicated the potential for the product in a number of different areas. For the past ten years we have been supplying investigators who have obtained an IND from the FDA.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
120 Wood Ave S, Iselin, NJ 08830, United States
Telephone
Telephone
(732)-603-7708
Client Website
Website
--
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

ABOUT THIS PAGE

Contact PEDIATRIC PHARMACEUTICALS INC and get a quotation

PEDIATRIC PHARMACEUTICALS INC is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Thalidomide bulk offered by PEDIATRIC PHARMACEUTICALS INC

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty